ResearchThe changing epidemiology of invasive mould diseases in immunosuppressed patients: what, why, how?
ResearchInvasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical Response
Jul 23, 2026Journal ArticleCandida glabrata Emerges as the Most Common Cause of Candidemia: Analysis of a Large Hospital-Based Database, United States, 2016-2024.Written by 1 Roon author & 5 others Via Clinical Infectious Diseases
ResearchPlasma Microbial Cell-Free DNA Sequencing for the Diagnosis of Chronic Disseminated Candidiasis in Patients with Hematologic Malignancies
Oct 8, 2026Journal ArticleUrinary Antigen Testing for Invasive Aspergillosis: Promise and Remaining Questions.Written by 1 Roon author & 1 other Via Clinical Infectious Diseases
ResearchCorticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series
ResearchPretransplant serologic testing for fungal infections in a large commercial health insurance database, United States
Feb 4, 2026Journal ArticleProtracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy.Written by 1 Roon author & 24 others Via Clinical Infectious Diseases
ResearchEpidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study
Dec 24, 2025Journal ArticleComparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study.Written by 2 Roon authors & 21 others Via Clinical Infectious Diseases
ResearchSafety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study
ResearchInvasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy
ResearchInvasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States
ResearchExpression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell Transplantation